Interview: siRNA-Loaded Stem Cell Exosomes, Inside NurExone Biologic’s Spinal Cord Injury Candidate
NurExone's SCI candidate showed 100% gait recovery in rat models, and they're gearing up for human trials hopefully in 2026. Enjoy the interview!
TheWell Bioscience Introduces VitroGel® NEURON, a Synthetic Hydrogel Enhancing Neuronal Cell Culture
Designed for 2D and 3D cultures, this platform aims to offer greater consistency and scalability in neuronal research.
Tel Aviv University to Implant Lab-Grown Spinal Cord in Human Trial, Derived from Stem Cells
Researchers have seen good success in animal studies, and are advancing to the first clinical trials in humans. What a time to be alive.
Indiana University Opens New Stem Cell Research Center for Alzheimer’s and Dementias
Indiana University’s new MAP-AD center will use stem-cell-derived brain models and AI to advance Alzheimer’s research and drug development.
Klotho Neurosciences to Acquire Turn Biotechnologies Assets, Secures $300 Million Deal
Klotho Neurosciences expands into cellular reprogramming with a planned Turn Biotechnologies acquisition and significant pharma partnership.
DarwinCell Presents Mesenchymal Stem Cell ALS Therapy at American Neurological Association Meeting
The Chinese biotech company shared promising preclinical and early clinical results for its novel ALS therapy
Aspen Neuroscience Begins Third Cohort in Parkinson’s Disease Stem Cell Therapy Trial with Commercial Formulation
Aspen’s trial advances with a commercial-ready, patient-derived cell therapy aiming to improve Parkinson’s outcomes and streamline clinical delivery.
BlueRock Therapeutics Begins Phase III Trial of Stem Cell Therapy for Parkinson’s Disease
The exPDite-2 trial will evaluate the safety and effectiveness of donor-derived stem cell therapy in Parkinson’s disease patients.
CIRM Approves $73 Million for Early-Stage Regenerative Medicine Research in California
The new grants will support diverse early-stage research projects, aiming to advance regenerative medicine tools and future therapies.
Orthocell’s Collagen Nerve Wrap, Remplir, Now Available to Australian Urologists for Prostate Surgery Recovery
Australian urologists can now access Remplir to support nerve protection and recovery during robotic prostate cancer surgeries.
RBI Launching Phase 2 Brain Stem Cell Injection Trial for Alzheimer’s
The trial will inject autologous stem cells directly into the brain to bypass the blood-brain-barrier.
DoD-Funded Stem Cell Trial Expands to Phase II for Traumatic Brain Injury
A new clinical trial in Texas will evaluate stem cell therapy’s potential to improve outcomes for adults with chronic TBI.
Orthocell Reports 81% Success Rate in Nerve Repair Study With Remplir
Interim study results highlight Remplir’s consistent safety and effectiveness in nerve repair, supporting further clinical and regulatory efforts.
Cedars-Sinai Sending Stem Cells to Space to Study Heart and Brain Organoids
Cedars-Sinai researchers will examine how microgravity affects the growth and development of heart and brain organoids in orbit.
Silk Based Nerve Repair Technology begins Trials
The first use of silk-based SilkAxons™ aims to address large peripheral nerve injuries where current treatments fall short.
NurExone Granted U.S. Patent for Exosome Manufacturing Process, Enhancing Supply Chain Capabilities
NurExone secures U.S. patent protection for its exosome production method, supporting scale-up and clinical supply chain readiness.
Hope Biosciences Awarded FDA RMAT Designation for Multiple Sclerosis Stem Cell Therapy
The FDA designation follows promising Phase II trial results for Hope Biosciences’ stem cell therapy in relapsing-remitting multiple sclerosis.
University of Auckland Leads Pioneering CRISPR Gene Therapy Trial for Muscular Dystrophy
Researchers are testing a novel CRISPR-based therapy for FSHD, with participants monitored for safety and long-term outcomes.
Regenerative Spinal Cord Therapy: Interview with Nurexone Biologic’s CEO, Dr. Lior Shaltiel
Nurexone Biologic has developed an exosome therapy for nerve repair, we interviewed the CEO, Dr. Lior Shaltiel here. Enjoy!
NurExone’s Exosomes Outperform Commercial Standard in Regenerative Study
Independent analysis finds NurExone’s exosomes deliver enhanced regenerative signals, showing promise for nerve repair and tissue healing applications.
Capricor Therapeutics Announces FDA Type A Meeting to Discuss Duchenne Muscular Dystrophy Treatment Path
Capricor Therapeutics is coordinating with the FDA on regulatory steps for its Duchenne therapy, with updates expected soon.
Sumitomo Pharma Submits Application for Japanese Approval of Stem Cell Therapy to Enhance Motor Function in Parkinson’s Disease
Sumitomo Pharma and RACTHERA seek approval for a novel iPS cell-based therapy targeting motor symptoms in advanced Parkinson’s.
NASA’s New Mission will Study Stem Cell Expansion in Space
The Crew-11 mission launched on Friday, where they will support studies in stem cell growth, organ tissue, bacteriophage therapy, and advanced computing.
Trailhead Biosystems Launches New iPSC-Derived Neurons for Parkinson’s Research
The iPSC-derived A9 dopaminergic neurons will hopefully offer researchers a human-based model for Parkinson’s disease studies.
New Trial: Umbilical Cord Stem Cell-Derived Exosome Nasal Drops for Neurodegenerative Diseases
Researchers will test whether nasal drops containing stem cell-derived vesicles can safely benefit people with a range of neurodegenerative diseases.